Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dana Farber Cancer Institute Inc
Original Assignee
Dana-Farber Cancer Institute
Thomas F. Tedder
Olivier G. Spertini
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dana-Farber Cancer Institute, Thomas F. Tedder, Olivier G. SpertinifiledCriticalDana-Farber Cancer Institute
Priority claimed from CA002112408Aexternal-prioritypatent/CA2112408C/en
Publication of CA2336561A1publicationCriticalpatent/CA2336561A1/en
Application grantedgrantedCritical
Publication of CA2336561CpublicationCriticalpatent/CA2336561C/en
Micro-Organisms Or Cultivation Processes Thereof
(AREA)
Preparation Of Compounds By Using Micro-Organisms
(AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Peptides Or Proteins
(AREA)
Abstract
A hybridoma cell line produced by the fusion of NS-1 myeloma cells with spleen cells obtained from mice immunized with Leukocyte Adhesion Molecule-1 (LAM-1) cDNA transfected cells. The cell line produces a monoclonal antibody reactive with human, monkey, cow, rabbit, sheep, dog, cat, pig and goat LAM-1. The monoclonal antibody produced by the cell line, anti-LAM1-3, may be clinically useful in blocking leukocyte entry into sites of inflammation or tissue injury.
CA002336561A1991-06-251992-06-24Monoclonal antibody to lymphocyte-associated cell surface protein
Expired - Fee RelatedCA2336561C
(en)
HUMAN MONOCLONE ANTIBODIES AGAINST A BACTERY TOXIN AND THEIR PREPARATION, CONTINUOUS CELL LINES, PRODUCING ANTITOXIN ANTIBODIES, AND ANTIBODIES 'USES
MONOCLONAL ANTIBODY SPECIFIC FOR A SEQUENCE OF FIBRONECTIN EXPRESSED IN TRANSFORMED HYBRIDOMA CELLS SECRETING THIS ANTIBODY AND USE OF THE MONOCLONAL ANTIBODY FOR THE DIAGNOSIS OF TUMORS.
SOLUBLE BETA LYMPHOTOXIN RECEPTORS, ANTIBODIES AGAINST LYMPHOTOXIN RECEPTORS AND ANTIBODIES AGAINST LYMPHOTOXIN LIGANDS AS THERAPEUTIC AGENTS FOR THE TREATMENT OF IMMUNOLOGY
Monoclonal antibodies directed against activated microglia cells,hybridomas secreting these monoclonal antibodies,antigen recognized by these monoclonal antibodies and their applications
Monoclonal antibodies involved in alzheimer's disease,hybridomas secreting these monoclonal antibodies,antigen recognized by these antibodies,and their application
Cocaine derivative, protein conjugate thereof, a hybridoma cell line producing a monoclonal antibody, process for producing the hybridoma cell line and the monoclonal antibody